Last reviewed · How we verify
IV fluorescein administration
At a glance
| Generic name | IV fluorescein administration |
|---|---|
| Sponsor | IHU Strasbourg |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma (PHASE3)
- Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study (NA)
- Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IV fluorescein administration CI brief — competitive landscape report
- IV fluorescein administration updates RSS · CI watch RSS
- IHU Strasbourg portfolio CI